Commission Report Proposes Solutions To European Shortages
Medicines For Europe Calls On European Commission To Take Immediate Action
Executive Summary
A European Commission study into the root causes of medicines shortages has identified a range of potential solutions, with the Commission identifying older, off-patent and generic drugs as the most at-risk.
You may also be interested in...
German Tamoxifen Shortage Shows Consequences Of Cost Containment
Supply issues around breast cancer treatment tamoxifen in Germany demonstrate the damaging effects of European cost-containment measures, Medicines for Europe has warned, citing an “urgent need to revise unsustainable pricing and tendering policies.”
German Tamoxifen Shortage Shows Consequences Of Cost Containment
Supply issues around breast cancer treatment tamoxifen in Germany demonstrate the damaging effects of European cost-containment measures, Medicines for Europe has warned, citing an “urgent need to revise unsustainable pricing and tendering policies.”
European Commission Steps Further Towards ‘Ambitious’ Pharma Legislation Reform
The incentives system, access to medicines, future proofing for novel products and antimicrobial resistance are just some of the topics included in a new consultation.